Overview
Background
Adam G. Stewart, BBiomedSci, MBBS (Hons), MPHTM, FRACP, FRCPA, PhD
Dr Adam Stewart is is an Australian-trained Infectious Diseases Physician and Clinical Microbiologist. He is currently working on clinical faculty as an Assistant Professor at the University of Texas MD Anderson Cancer Center in Houston, USA. He has previously undertaken post-fellowship subspeciality training in Transplant Infectious Diseases at Massachusetts General Hospital and Harvard University. Dr Stewart is an active physician-scientist with interests in clinical trials, invasive fungal disease, and infections in oncology and transplant patients. Dr Stewart is committed to advancing the management of infections in cancer patients.
Availability
- Dr Adam Stewart is:
- Available for supervision
- Media expert
Qualifications
- Bachelor of Biomedical Science, Griffith University
- Bachelor of Medicine and Surgery and Medical Science, Griffith University
- Masters (Coursework) of Public Health and Tropical Medicine, James Cook University
Research interests
-
Invasive fungal disease
Clinical and translational research on the causes of early treatment failure and refractory infection in haematological malignancy patients
-
Fungal diagnostics
Fungal pathogenesis research; host and pathogen biomarker discovery for clinical use for diagnostic and prognostic purposes
-
Clinical trials
Novel clinical trial design for rare or uncommon pathogens including those causing invasive fungal disease
Works
Search Professor Adam Stewart’s works on UQ eSpace
2026
Journal Article
The impact of geography and antimicrobial resistance on the incidence and outcomes of Elizabethkingia species bloodstream infection
Stewart, Adam G., Edwards, Felicity and Laupland, Kevin B. (2026). The impact of geography and antimicrobial resistance on the incidence and outcomes of Elizabethkingia species bloodstream infection. Diagnostic Microbiology and Infectious Disease, 114 (1) 117106, 1-4. doi: 10.1016/j.diagmicrobio.2025.117106
2025
Journal Article
Differences in clinical outcomes among patients with mold fungemia
Stewart, Adam G., Laupland, Kevin B., Edwards, Felicity, Chen, Sharon C-A. and Slavin, Monica A. (2025). Differences in clinical outcomes among patients with mold fungemia. Open Forum Infectious Diseases, 13 (1) ofaf793. doi: 10.1093/ofid/ofaf793
2025
Journal Article
Convalescent plasma in hospitalised patients with COVID-19
Mcquilten, Zoe, O'sullivan, Matthew V. N., Purcell, Damien, Edler, Peta, Meagher, Niamh, Alcorn, Kylie, Bowen, Asha, Daly, James, Foo, Hong, Goulding, Susan, Gosbell, Iain, Hammond, Naomi, Hills, Thomas, Hoad, Veronica, Jha, Vivekanand, Lim, Lyn Li, Mcphee, Grace, Molton, James, Morpeth, Susan, Nguyen, Vi, Paterson, David, Rees, Megan, Roberts, Jason, Rogers, Benjamin A., Stewart, Adam, Sasadeusz, Joe, Snelling, Thomas, Venkatesh, Balasubramanian, Wood, Erica ... Denholm, Justin T. (2025). Convalescent plasma in hospitalised patients with COVID-19. Internal Medicine Journal, 55 (12) imj.70253, 2024-2032. doi: 10.1111/imj.70253
2025
Journal Article
Bloodstream infection and risk for plasma cell neoplasms: a population‐based cohort study
Stewart, Adam G., Edwards, Felicity and Laupland, Kevin B. (2025). Bloodstream infection and risk for plasma cell neoplasms: a population‐based cohort study. Transplant Infectious Disease, 27 (6) e70110. doi: 10.1111/tid.70110
2025
Journal Article
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial
Paterson, David L., Sulaiman, Helmi, Liu, Po-Yu, Chatfield, Mark D., Yilmaz, Mesut, Salmuna, Zeti Norfidiyati, Mazlan, Mohd Zulfakar, Anunnatsiri, Siriluck, Sirijatuphat, Rujipas, Chotiprasitsakul, Darunee, Lye, David C., Somani, Jyoti, Kalimuddin, Shirin, Aslan, Abdullah T., Thamlikitkul, Visanu, Lee, Yi-Tzu, Yang, Ya-Sung, Lin, Yi-Tsung, Ramli, Wan Nurliyana Wan, Tseng, Chien-Hao, Archuleta, Sophia, Chan, Yvonne Fu Zi, Forde, Brian M., Wright, Hugh, Stewart, Adam G., Ramsay, Kay A., Ling, Weiping, Rossi, Vicki, Harris-Brown, Tiffany M. and Harris, Patrick N. A. (2025). Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial. The Lancet Infectious Diseases, 26 (2), 148-159. doi: 10.1016/s1473-3099(25)00469-4
2025
Other Outputs
Treatment strategies for extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales
Stewart, Adam (2025). Treatment strategies for extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/28ac0b5
2025
Journal Article
Clinical Characteristics and Outcomes in Patients With Cryptococcaemia From a Large Population-Based Cohort
Stewart, Adam G., Laupland, Kevin B., Edwards, Felicity, Gassiep, Ian, Koo, Sophia, Hammond, Sarah P., Chen, Sharon C.-A. and Slavin, Monica A. (2025). Clinical Characteristics and Outcomes in Patients With Cryptococcaemia From a Large Population-Based Cohort. Mycoses, 68 (7) e70091, e70091-7. doi: 10.1111/myc.70091
2025
Journal Article
Epidemiology, Significance and Clinical Outcomes of Bloodstream Infections Caused by Non‐<i>Candida</i> and Non‐<i>Cryptococcus</i> Yeasts
Stewart, Adam G., Laupland, Kevin B., Edwards, Felicity, Slavin, Monica A. and Chen, Sharon C.‐A. (2025). Epidemiology, Significance and Clinical Outcomes of Bloodstream Infections Caused by Non‐Candida and Non‐Cryptococcus Yeasts. Mycoses, 68 (7) e70093, e70093. doi: 10.1111/myc.70093
2025
Journal Article
Population-based longitudinal study over two decades of Candida and Candida-like species bloodstream infection reveals gender and species differences in mortality, recurrence and resistance
Stewart, Adam G., Laupland, Kevin B., Edwards, Felicity, Koo, Sophia, Hammond, Sarah P., Harris, Patrick N. A., Paterson, David L., Slavin, Monica A. and Chen, Sharon C-A (2025). Population-based longitudinal study over two decades of Candida and Candida-like species bloodstream infection reveals gender and species differences in mortality, recurrence and resistance. Journal of Infection, 91 (1) 106513, 1-11. doi: 10.1016/j.jinf.2025.106513
2025
Journal Article
Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trial
Stewart, Adam G., Harris, Patrick N. A., Graham, Rikki M. A., Jennison, Amy V., Schlebusch, Sanmarie, Kakkanat, Asha, Harris-Brown, Tiffany, Paterson, David L. and Forde, Brian M. (2025). Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trial. Therapeutic Advances in Infectious Disease, 12 20499361251337597, 1-12. doi: 10.1177/20499361251337597
2025
Journal Article
Unravelling T cell immunity in CAR-T therapy: implications for influenza vaccination
Stewart, Adam G. and Chemaly, Roy F. (2025). Unravelling T cell immunity in CAR-T therapy: implications for influenza vaccination. Transplantation and Cellular Therapy, 31 (5), 282-284. doi: 10.1016/j.jtct.2025.04.003
2025
Journal Article
Population pharmacokinetic modelling of remdesivir and its metabolite GS-441524 in hospitalised patients with COVID-19
Roberts, Darren M., Liu, Xin, Parker, Suzanne L., Burke, Andrew, Peek, Jenny, Carland, Jane E., Murnion, Bridin, Seah, Vincent, Wallis, Steven C., Sumi, Chandra D., Pandey, Saurabh, Buscher, Hergen, Byrne, Anthony, Sandaradura, Indy, Bowen, David, Holz, Simon, Stewart, Adam G., Hajkowicz, Krispin M. and Roberts, Jason A. (2025). Population pharmacokinetic modelling of remdesivir and its metabolite GS-441524 in hospitalised patients with COVID-19. Clinical Pharmacokinetics, 64 (5) e0022222, 743-756. doi: 10.1007/s40262-025-01496-2
2025
Journal Article
Community-onset bloodstream infection among people with opioid use disorders: a twenty-year population-based cohort study in Queensland, Australia
Laupland, Kevin B., Stewart, Adam G., Edwards, Felicity, Harris, Patrick N. A. and Coulter, Sonali (2025). Community-onset bloodstream infection among people with opioid use disorders: a twenty-year population-based cohort study in Queensland, Australia. Infectious Diseases, 57 (7), 669-675. doi: 10.1080/23744235.2025.2471823
2025
Journal Article
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation
Stewart, Adam G. and Chambers, Daniel C. (2025). Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation. The Journal of Heart and Lung Transplantation, 44 (3), 435-436. doi: 10.1016/j.healun.2024.11.043
2025
Journal Article
Klebsiella pneumoniae species complex bloodstream infection in adult patients: changing epidemiology and determinants of poor outcomes
Stewart, Adam G., Harris, Patrick N. A., Edwards, Felicity, Kiani, Behzad, Paterson, David L. and Laupland, Kevin B. (2025). Klebsiella pneumoniae species complex bloodstream infection in adult patients: changing epidemiology and determinants of poor outcomes. Infection, 53 (3), 1179-1187. doi: 10.1007/s15010-024-02457-w
2025
Journal Article
Rezafungin acetate for the treatment of candidemia and invasive candidiasis: a pharmacokinetic evaluation
Bassetti, Matteo, Stewart, Adam, Bartalucci, Claudia, Vena, Antonio, Giacobbe, Daniele Roberto and Roberts, Jason (2025). Rezafungin acetate for the treatment of candidemia and invasive candidiasis: a pharmacokinetic evaluation. Expert Opinion On Drug Metabolism and Toxicology, 21 (2), 125-132. doi: 10.1080/17425255.2024.2424899
2024
Journal Article
Risk of mortality in Fusobacterium species bloodstream infection from a large Australian cohort
Stewart, Adam G., Edwards, Felicity, Harris, Patrick N. A., Paterson, David L. and Laupland, Kevin B. (2024). Risk of mortality in Fusobacterium species bloodstream infection from a large Australian cohort. European Journal of Clinical Microbiology and Infectious Diseases, 44 (2), 427-436. doi: 10.1007/s10096-024-05012-5
2024
Journal Article
<i>Yersinia enterocolitica</i> Pneumonia in a Heart Transplant Recipient
Portales Castillo, Carlos Alejandro, Stewart, Adam G. and Kotton, Camille N. (2024). Yersinia enterocolitica Pneumonia in a Heart Transplant Recipient. Transplant Infectious Disease, 27 (1) e14422, e14422. doi: 10.1111/tid.14422
2024
Journal Article
Diagnosis and management of invasive fungal diseases by next-generation sequencing: are we there yet?
Babady, N. Esther, Chiu, Charles Y., Craney, Arryn, Gaston, David C., Hicklen, Rachel S., Hogan, Catherine A., John, Teny M. and Stewart, Adam G. (2024). Diagnosis and management of invasive fungal diseases by next-generation sequencing: are we there yet?. Expert Review of Molecular Diagnostics, 24 (12), 1083-1096. doi: 10.1080/14737159.2024.2436396
2024
Journal Article
An update on recent clinical trial data in bloodstream infection
Stewart, Adam G., Simos, Peter, Sivabalan, Pirathaban, Escolà-Vergé, Laura, Garnham, Katherine, Isler, Burcu and ESGBIES Study Group (2024). An update on recent clinical trial data in bloodstream infection. Antibiotics, 13 (11) 1035, 1-14. doi: 10.3390/antibiotics13111035
Funding
Past funding
Supervision
Availability
- Dr Adam Stewart is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Media
Enquiries
Contact Dr Adam Stewart directly for media enquiries about:
- clinical trial
- infectious diseases
- superbugs
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: